Tardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia [1]

Canadian Journal of Psychiatry

Volumn 49, Issue 5, 2004, Pages 343-

  Bhanji, Nadeem H ^a   Margolese, Howard C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAZEPAM; NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; PAROXETINE; TOPIRAMATE;

ADULT; ALCOHOL ABUSE; CASE REPORT; HUMAN; LETTER; MAJOR DEPRESSION; MALE; SCHIZOPHRENIA; SUBSTANCE ABUSE; TARDIVE DYSKINESIA; WITHDRAWAL SYNDROME;

EID: 2642543874     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404900515     Document Type: Letter

References (8)

1. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 2002;16:23-45.
2. Ananth J, Kenan J. Tardive dyskinesia associated with olanzapine monotherapy. J Clin Psychiatry 1999;60:870.
3. Herrán A, Vázquez-Barquero JL. Tardive dyskinesia associated with olanzapine. Ann Intern Med 1999;131:72.
4. Snoddgrass PL. Tardive dyskinesia from risperidone and olanzapine in an alcoholic man. Can J Psychiatry 1999;44:921.
5. Chouinard G, Ross-Chouinard A, Annable L. Extrapyramidal Symptom Rating Scale (ESRS). Can J Neurol Sci 1980;7:233-4.
6. Sakai K, Gao XM, Hashimoto T, Tamminga CA. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse 2001;39:152-60.
7. Benazzi F. Rapid onset of tardive dyskinesia in Huntington dizease with olanzapine. J Clin Psychopharmacol 2002;22:438-9.
8. Keck PE, McElroy SL. Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. J Clin Psychiatry 2002;63(Suppl 4):3-11.